Alzheimer's Disease

Clinical Trials

Below is a list of Alzheimer's Disease clinical trials from the clinical trials database at Mayo Clinic.

This list includes only trials about which Mayo researchers choose to publish information. Mayo Clinic may be conducting other trials which are not in this database. Mayo's clinical trials include experimental treatments, often unavailable elsewhere, which frequently lead to improved patient care for people worldwide. Patients should ask their doctor at Mayo about clinical trials appropriate for their situation.

Receptor for Glycation End Products (RAGE)
This study is being done to evaluate whether the use of the study medicine PF-04494700 is able to change the rate of cognitive decline in subjects with Alzheimer's disease (AD).

In this study, people with AD will be given placebo (a pill that does not have any drug) or one of two doses of PF-04494700 for 18 months to determine whether daily PF-04494700 therapy is beneficial in delaying or altering deterioration in memory and daily functioning.
Read more